Global cancer patterns: Causes and prevention

The Lancet

Volumn 383, Issue 9916, 2014, Pages 549-557

  Vineis, Paolo ^a,b   Wild, Christopher P ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b School of Public Health and HuGeF Foundation   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE; ASBESTOS; BENZENE; BENZIDINE; BERYLLIUM; CADMIUM; CARCINOGEN; CHROMIUM; NICKEL;

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; COLORECTAL CANCER; DIET; DIGESTIVE SYSTEM CANCER; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; HEALTH; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HUMAN; LEUKEMIA; LIVER CANCER; LOWEST INCOME GROUP; LUNG CANCER; MALNUTRITION; MESOTHELIOMA; NEOPLASM; OBESITY; OCCUPATIONAL EXPOSURE; OVERNUTRITION; PAPILLOMAVIRUS INFECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; SMOKING; STOMACH CANCER; TOBACCO; UNDERWEIGHT; UTERINE CERVIX CANCER;

EID: 84895901860     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62224-2     Document Type: Review

References (93)

1. Wild CP. The role of cancer research in noncommunicable disease control. J Natl Cancer Inst 2012; 104: 1051-58.
2. Zablocki RW, Edland SD, Myers MG, Strong DR, Hofstetter CR, Al-Delaimy WK. Smoking ban policies and their influence on smoking behaviors among current California smokers: a population-based study. Prev Med 2013; published online Nov 26. DOI:S0091-7435(13)00452-0.
3. Beral V, Alexander M, Duffy S, et al. The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer. J Med Screen 2011; 18: 210-12.
4. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012; 13: 790-801.
5. Wagner K-H, Brath H. A global view on the development of non communicable diseases. Prev Med 2012; 54 (suppl): S38-41.
6. Giovino GA, Mirza SA, Samet JM, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380: 668-79.
7. Tanumihardjo SA, Anderson C, Kaufer-Horwitz M, et al. Poverty, obesity, and malnutrition: an international perspective recognizing the paradox. J Am Diet Assoc 2007; 107: 1966-72.
8. Bray F, Ren J-S, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013; 132: 1133-45.
9. GLOBOCAN 2008. Available from http://globocan.iarc.fr/.
10. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010; 11: 165-73.
11. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010; 376: 1186-93.
12. Sylla BS, Wild CP. A million Africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer 2012; 130: 245-50.
13. Abdel-Wahab M, Bourque J-M, Pynda Y, et al. Status of radiotherapy resources in Africa: an international atomic energy agency analysis. Lancet Oncol 2013; 14: e168-75.
14. Denny L. Cervical cancer: prevention and treatment. Discov Med 2012; 14: 125-31.
15. Harford JB. Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol 2011; 12: 306-12.
16. De Gelder R, Heijnsdijk EAM, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011; 33: 111-21.
17. Ormiston-Smith N, Scowcroft H, Thomson CS. Mortality benefits and overdiagnosis estimates for women attending breast screening. Br J Cancer 2013; 108: 2413-14.
18. Miller AB. Overdiagnosis of breast cancer. Int J Cancer 2013; 133: 2511.
19. The Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. October 2012 p. 1-118. http://www.cancerresearchuk.org/prod-consump/groups/cr-common/@nre/@hea/ documents/generalcontent/ibsr-fullreport.pdf (accessed Dec 6, 2013).
20. Eheman C, Henley SJ, Ballard-Barbash R, et al. Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012; 118: 2338-66.
21. International Agency for Research on Cancer. Cancer incidence in five continents vol. IX. 2007 p. 1-961. Eds Curado MP, Edwards B, Shin HR, et al. http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/ (accessed Dec 6, 2013).
22. Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA. International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev 2010; 19: 1151-59.
23. American Cancer Society. Colorectal cancer facts & figures 2011-13. 2011. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-028323.pdf (accessed Dec 6, 2013).
24. McGlynn KA, London WT The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 2011; 15: 223-43, vii-x.
25. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 2006; 367: 52-56.
26. WHO. Global status report on non-communicable diseases 2010. p 1-162. http://www.who.int/chp/ncd-global-status-report/en/
27. De Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-15.
28. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.
29. Pirie K, Peto R, Reeves GK, Green J, Beral V. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 2013; 381: 133-41.
30. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. http://www.iarc.fr/en/publications/list/handbooks/index.php (accessed Dec 6, 2013).
31. Cokkinides V, Bandi P, McMahon C, Jemal A, Glynn T, Ward E. Tobacco control in the United States-recent progress and opportunities. CA Cancer J Clin 59: 352-65.
32. Moodie R, Stuckler D, Monteiro C, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet 2013; 381: 670-79.
33. Hagger-Johnson G, Bell S, Britton A, et al. Cigarette smoking and alcohol drinking in a representative sample of English school pupils: cross-sectional and longitudinal associations. Prev Med 2013; 56: 304-08.
34. Patel D, Kassim S, Croucher R. Tobacco promotion and availability in school neighborhoods in India: a cross-sectional study of their impact on adolescent tobacco use. Asian Pac J Cancer Prev 2012; 13: 4173-76.
35. Meigs JW, Marrett LD, Ulrich FU, Flannery JT. Bladder tumor incidence among workers exposed to benzidine: a thirty-year follow-up. J Natl Cancer Inst 1986; 76: 1-8.
36. International Agency for Research on Cancer. Overall evaluation of carcinogenity: an updating of IARC monographs 1987 p. 1-440. http://monographs.iarc.fr/ENG/Monographs/suppl7/index.php (accessed Dec 6, 2013).
37. Richardson DB. Temporal variation in the association between benzene and leukemia mortality. Environ Health Perspect 2008; 116: 370-74.
38. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005; 92: 587-93.
39. Weill H, Hughes JM, Churg AM. Changing trends in US mesothelioma incidence. Occup Environ Med 2004; 61: 438-41.
40. Burdorf A, Järvholm B, Englund A. Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands. Int J Cancer 2005; 113: 298-301.
41. Magnani C, Ferrante D, Barone-Adesi F, et al. Cancer risk after cessation of asbestos exposure: a cohort study of Italian asbestos cement workers. Occup Environ Med 2008; 65: 164-70.
42. McCormack VA, Schüz J. Africa's growing cancer burden: environmental and occupational contributions. Cancer Epidemiol 2012; 36: 1-7
43. Park J, Hisanaga N, Kim Y. Transfer of occupational health problems from a developed to a developing country: lessons from the Japan-South Korea experience. Am J Ind Med 2009; 52: 625-32.
44. World Cancer Research Fund. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. 2007 p. 1-517 http://www. dietandcancerreport.org/expert-report/report-contents/index.php (accessed Dec 6, 2013).
45. Clague J, Bernstein L. Physical activity and cancer. Curr Oncol Rep 2012; 14: 550-58.
46. Friedenreich CM, Neilson HK, Lynch BM. State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 2010; 46: 2593-604.
47. Romaguera D, Vergnaud A-C, Peeters PH, et al. Is concordance with World Cancer Research F und/ American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr 2012; 96: 150-63.
48. Boeing H, Bechthold A, Bub A, et al. Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr 2012; 51: 637-63.
49. Boffetta P, Couto E, Wichmann J, et al. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2010; 102: 529-37
50. Ahn J, Abnet CC, Cross AJ, Sinha R. Dietary intake and nutritional status IARC Sci Publ 2011; 163: 189-98.
51. Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science 2012; 336: 1262-67
52. Herceg Z, Vaissière T. Epigenetic mechanisms and cancer: an interface between the environment and the genome. Epigenetics 2011; 6: 804-19.
53. Wild CP. The exposome: from concept to utility. Int J Epidemiol 2012; 41: 24-32.
54. Wand H, Ramjee G. High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa: healthy diet and life style messages should be integrated into HIV prevention programs. BMC Public Health 2013; 13: 159.
55. Ezzati M, Vander Hoorn S, Lawes CMM, et al. Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. Novotny T, editor. PLoS Med 2005; 2: e133.
56. Peer N, Bradshaw D, Laubscher R, Steyn N, Steyn K. Urban-rural and gender differences in tobacco and alcohol use, diet and physical activity among young black South Africans between 1998 and 2003. Glob Health Action 2013; 6: 19216.
57. Wigle J, Coast E, Watson-Jones D. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. Vaccine 2013; 31: 3811-17
58. Herrero R, Wacholder S, Rodríguez AC, et al. Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discov 2011; 1: 408-19.
59. Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet 2013; 382: 889-899.
60. Chang M-H, You S-L, Chen C-J, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009; 101: 1348-55.
61. Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: epidemiology and prevention in developing countries. World J Hepato 2012; 4: 74-80.
62. Vineis P, Xun W The emerging epidemic of environmental cancers in developing countries. Ann Oncol 2009; 20: 205-12.
63. Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst 2011; 103: 1827-39.
64. Nweke OC, Sanders WH. Modern environmental health hazards: a public health issue of increasing significance in Africa. Environ Health Perspect 2009; 117: 863-70.
65. UN Environment Programme. Global Chemicals Outlook: towards sound management of chemicals. 2012. p. 1-44. http://www.unep.org/pdf/GCO- Synthesis%20Report-CBDTIE-UNEP-September5-2012.pdf (accessed Dec 6, 2013).
66. Benbrahim-Tallaa L, Baan RA, Grosse Y, et al. Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes. Lancet Oncol 2012; 13: 663-64.
67. Baan R, Grosse Y, Lauby-Secretan B, et al. Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol 2011; 12: 624-26.
68. Alavanja MCR, Bonner MR. Occupational pesticide exposures and cancer risk: a review. J Toxicol Env Health B Crit Rev 2012; 15: 238-63.
69. Richardson SD, Plewa MJ, Wagner ED, Schoeny R, Demarini DM. Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: a review and roadmap for research. Mutat Res 2007; 636: 178-242.
70. Ward EM, Schulte PA, Straif K, et al. Research recommendations for selected IARC-classified agents. Environ Health Perspect 2010; 118: 1355-62.
71. Darby S, Hill D, Doll R. Radon: a likely carcinogen at all exposures. Ann Oncol 2001; 12: 1341-51.
72. Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 2012; 345: e4757.
73. Tucker MA. Melanoma epidemiology. Hematol Oncol Clin North Am 2009; 23: 383-95, vii.
74. Erdmann F, Lortet-Tieulent J, Schüz J, et al. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer 2013; 132: 385-400.
75. Makin JK, Warne CD, Dobbinson SJ, Wakefield MA, Hill DJ. Population and age-group trends in weekend sun protection and sunburn over two decades of the SunSmart programme in Melbourne, Australia. Br J Dermatol 2013; 168: 154-61.
76. Lovasi GS, Hutson MA, Guerra M, Neckerman KM. Built environments and obesity in disadvantaged populations. Epidemiol Rev 2009; 31: 7-20.
77. Dowell D, Farley TA. Prevention of non-communicable diseases in New York City. Lancet 2012; 380: 1787-89.
78. Oreskes N, Conway E. Merchants of doubt: how a handful of scientists obscured the truth on issues from tobacco smoke to global warming. New York City: Bloomsbury Press, 2010.
79. Gallo V, Mackenbach JP, Ezzati M, et al. Social inequalities and mortality in Europe-results from a large multi-national cohort. Behrens T, ed. PLoS One 2012; 7: e39013.
80. Nagel G, Linseisen J, Boshuizen HC, et al. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Epidemiol 2007; 36: 66-76.
81. Menvielle G, Boshuizen H, Kunst AE, et al. The role of smoking and diet in explaining educational inequalities in lung cancer incidence. J Natl Cancer Inst 2009; 101: 321-30.
82. Rohrmann S, Steinbrecher A, Linseisen J, et al. The association of education with long-term weight change in the EPIC-PANACEA cohort. Eur J Clin Nutr 2012; 66: 957-63.
83. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191-308.
84. The Marmot Review Team. 'Fair Society Healthy Lives' (The Marmot Review) September, 2010. http://www.instituteofhealthequity.org/projects/fair-society- healthy-lives-the-marmot-reviewMarmot (accessed Dec 6, 2013).
85. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011; 105 (suppl): S77-81.
86. Ebrahim S, Smith GD. Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol 2001; 30: 201-05.
87. Joshi R, Chow CK, Raju PK, et al. The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. J Am Coll Cardiol 2012; 59: 1188-96.
88. Sampath P, Wilson D. A case study and state of science review: private versus public healthcare financing. Glob J Health Sci 2012; 4: 118-26.
89. Kondilis E, Giannakopoulos S, Gavana M, Ierodiakonou I, Waitzkin H, Benos A. Economic crisis, restrictive policies, and the population's health and health care: the Greek case. Am J Public Health 2013; 103: 973-79.
90. Sullivan R, Homberg L, Purushotham AD. Cancer risk and prevention in a globalised world: solving the public policy mismatch. Eur J Cancer 2012; 48: 2043-45.
91. Fineberg H V. The paradox of disease prevention: celebrated in principle, resisted in practice. JAMA 2013; 310: 85-90.
92. Knaul FM, Gralow JR, Atun R, Bhadelia A, eds. Closing the cancer divide. An equity imperative. Harvard University Press, Cambridge, MA, USA: 2012. p. 1-404.
93. Atun R, Jaffar S, Nishtar S, et al. Improving responsiveness of health systems to non-communicable diseases. Lancet 2013; 381: 690-97.